Related Experiment Video
Updated: May 25, 2026
12:13
Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
Interrogating genomic and epigenomic data to understand prostate cancer
1Division of Hematology/Oncology, Department of Medicine, Northwestern University, Feinberg School of Medicine, Chicago, IL 60611, USA.
Biochimica Et Biophysica Acta
|January 14, 2012
Summary
High-throughput technologies like next-generation sequencing (NGS) have revolutionized prostate cancer research. Discoveries include gene fusions and oncogenes, enhancing our understanding of transcriptional regulation and androgen receptor activity.
Area of Science:
- Genomics and Molecular Biology
- Cancer Research
- Epigenetics
Background:
- High-throughput technologies have transformed biological research, yielding significant insights into diseases like cancer.
- Prostate cancer research has benefited immensely from advancements in microarray and next-generation sequencing (NGS) technologies.
Purpose of the Study:
- To review key discoveries in prostate cancer research driven by high-throughput approaches.
- To highlight the role of genomic and epigenomic data in understanding transcriptional regulation.
- To illustrate mechanisms of androgen receptor (AR) binding and regulation.
Main Methods:
- Review of studies utilizing microarrays and next-generation sequencing (NGS) in prostate cancer.
- Analysis of genomic and epigenomic data to understand transcriptional regulation.
- Examination of protein-DNA interactions, histone modifications, and chromatin structure.
Main Results:
- Identification of critical genetic alterations in prostate cancer, including TMPRSS2-ERG gene fusions.
- Discovery of oncogenes such as EZH2, a polycomb group protein.
- Elucidation of complex transcriptional regulation mechanisms influenced by AR.
Conclusions:
- High-throughput technologies are pivotal for advancing prostate cancer research and understanding its molecular basis.
- Genomic and epigenomic analyses provide deep insights into gene regulation and disease mechanisms.
- Further research into AR signaling and epigenetic modifications holds promise for therapeutic strategies.
